Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gamma-aminobutyric acid type A (GABA_A) receptor alpha-3 beta-2 gamma-2 is a heteropentameric ligand-gated ion channel that serves as a primary mediator of fast inhibitory neurotransmission in the central nervous system [1, 2]. It is composed of two alpha-3, two beta-2, and one gamma-2 subunits, forming a central pore permeable to chloride and bicarbonate ions [4, 9]. Upon binding of the endogenous neurotransmitter GABA, the channel opens, leading to hyperpolarization of the postsynaptic neuron and a decrease in its excitability [6, 7]. This specific subtype is notably expressed in the reticular nucleus of the thalamus, the spinal cord dorsal horn, and the basal ganglia, playing a critical role in sensory processing, muscle tone, and anxiety regulation [9, 31]. Pharmacologically, it is a target for benzodiazepines and other allosteric modulators, which enhance the receptor's response to GABA [12, 15]. Research into alpha-3-selective modulators aims to develop treatments for chronic pain and anxiety that lack the sedative side effects typically associated with alpha-1-containing GABA_A receptors [25, 32]. Dysregulation or mutations in the subunits of this receptor are linked to conditions such as epilepsy, autism, and chronic pain syndromes [8, 11, 32].
Positive allosteric modulation of the GABA-A receptor chloride channel, increasing chloride ion conductance and causing neuronal hyperpolarization.
14 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-3 beta-2 gamma-2 (GABA_A receptor α3β2γ2) (GABA_A receptor α3β2γ2).